期刊文献+

多囊卵巢综合征患者控制性促排卵策略研究进展 被引量:11

Progress in Controlled Ovarian Stimulation Protocols of Polycystic Ovary Syndrome
下载PDF
导出
摘要 多囊卵巢综合征(PCOS)是临床常见的妇科内分泌紊乱综合征,是引起育龄期女性无排卵性不孕的主要原因。由于内分泌的紊乱,在体外受精-胚胎移植(IVF-ET)过程中,PCOS患者对药物的反应难以预测,控制性促排卵(COS)过程中极易出现卵巢反应不良、卵巢过度刺激综合征(OHSS)等现象。目前,PCOS患者IVF促排卵过程中常用的方案有长方案、拮抗剂方案、微刺激方案、改良超长方案、超长方案、未成熟卵母细胞体外培养成熟(IVM)等,其中长方案是多数生殖中心目前最常用的方案,微刺激方案和拮抗剂方案作为新的非降调节治疗策略,近年越来越受重视。改良超长方案及超长方案作为对传统方案的探索改进,在临床中也取得了一定的效果,而IVM作为一种新的技术,在简化治疗的同时显著降低了OHSS的发生。对PCOS不孕患者进行辅助生殖过程中,制定个体化治疗方案以获得优质卵子和胚胎,并避免OHSS等并发症的发生,是目前临床工作中需解决的关键问题。 Polycystic ovary syndrome(PCOS),a common clinical endocrine disorder,is the main cause of anovulatory infertility in women of childbearing age. Due to the particular endocrine disorders in PCOS patients,it is hard to predict ovarian responses to drugs during controlled ovarian stimulation(COS). So,poor ovarian responses and ovarian hyperstimulation syndrome(OHSS) are incredibly common. The common protocols used in IVF for PCOS patients include long protocol,antagonist protocol,mild stimulation protocol, revised super-long protocol,super-long protocol and in vitro maturation(IVM). Presently,long protocol is most frequently used in most of reproductive centers. At the same time,antagonist protocol and mild stimulation protocol,as new protocols,are gradually favored by many clinicians. Super-long protocol and the revised super-long protocol,as the improved traditional protocols,have also obtained good clinic results. IVM,as a technical innovation, can simplify treatment and reduce the risk of OHSS. During IVF for patients with PCOS,it is the key point for clinicians to choose the optimal and economical treatment,to get high-quality eggs and embryos, and to avoid complications such as OHSS.
出处 《国际生殖健康/计划生育杂志》 CAS 2015年第2期148-152,共5页 Journal of International Reproductive Health/Family Planning
基金 郑州市科技创新团队项目(113PCXTD435)
关键词 多囊卵巢综合征 受精 体外 胚胎移植 排卵诱导 Polycystic ovary syndrome Fertilization in vitro Embryo transfer Ovulation induction
  • 相关文献

参考文献32

  • 1Li R,Zhang Q,Yang D,et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study [J]. Hum Reprod, 2013,28(9 ) : 2562-2569.
  • 2Chen ZJ, Shi Y. Polycystic ovary syndrome [J]. Front Med China, 2010,4(3) :280-284.
  • 3Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome[J]. Hum Reprod, 2008,23 ( 3 ) : 462-477.
  • 4张少娣,路锦,耿嘉瑄,张翠莲.hCG注射日雌二醇(E_2)增幅及每成熟卵泡E_2水平对控制性促排卵hCG扳机的影响[J].生殖与避孕,2014,34(5):415-420. 被引量:4
  • 5Marcus SF, Ledger WL. Efficacy and safety of long-acting GnRH agonists in in vitro fertilization and embryo transfer [J]. Hum Fertil (Camb),2001,4(2) : 85-93.
  • 6Venetis CA,Kolibianakis EM,Bosdou JK,et al. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles [J]. Hum Reprod Update, 2013,19 ( 5 ) : 433-457.
  • 7Elnashar AM. Progesterone rise on the day of HCG administration (premature luteinization) in tVF: an overdue update [J]. J Assist Reprod Genet, 2010,27 (4) : 149-155.
  • 8Lainas TG,Sfontouris IA,Zorzovilis IZ,et al. Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)[J]. Hum Reprod, 2010,25 (3) : 683-689.
  • 9Lin H,Li Y,Li L,et al. Is a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs [J]. PLoS One,2014,9 (3) : e91796.
  • 10Xiao J, Chen S, Zhang C, et al. Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis[J]. Gynecol Endocrinol, 2013,29(3) : 187-191.

二级参考文献78

  • 1陈骞,牛志宏,张韶珍,徐步芳,冯云.体外受精周期中注射hCG日雌激素水平对妊娠结局的影响[J].上海交通大学学报(医学版),2011,31(7):980-983. 被引量:13
  • 2邵明君,叶碧绿,赵军招,林金菊,林文琴,黄学锋.体外受精-胚胎移植在多囊卵巢综合征不育患者中的应用[J].生殖医学杂志,2005,14(1):10-12. 被引量:20
  • 3章汉旺,李莉,李清,邓彧,段秀娟.来曲唑和克罗米酚对小鼠着床期子宫内膜容受性的影响[J].生殖与避孕,2007,27(4):251-254. 被引量:27
  • 4Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril, 2001,75(2):305-9.
  • 5Mitwally MF, Casper RF. Aromatase inhibition for ovarian stimulation: future avenues for infertility management. Curr Opin Obstet Gynecol, 2002, 14(3):255-63.
  • 6The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod, 2004 19(1):41-7.
  • 7Requena A, Herrero J, Landeras J, et al. Use of letrozole in assisted reproduction: a systematic review and meta-analysis. Hum Reprod Update, 2008, 14(6):571-82.
  • 8Goswami SK, Das T, Chattopadhyay R, et al. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Hum Reprod, 2004, 19(9):2031-5.
  • 9Bosch E, Valencia I, Escudero E, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril, 2003, 80(6): 1444-9.
  • 10Segal S, Glatstein I, McShane P, et al. Premature luteinization and in vitro fertilization outcome in gonadotropin/gonadotropin-releasing hormone antagonist cycles in women with polycystic ovary Syndrome. Fertil Steril, 2009, 91(5): 1755-9.

共引文献60

同被引文献77

引证文献11

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部